BioSpace News Archive

Marinus Pharmaceuticals, Inc. today announced that it has entered into a revenue interest financing agreement with Sagard Healthcare Partners for a total of $32.5 million upfront in return for payments based on U.S. net sales of ganaxolone, including the recently approved ZTALMY® (ganaxolone) oral suspension CV.

Castle Biosciences, Inc. (Nasdaq: CSTL) today announced the publication of real-world clinical utility data in Cancer Investigation showing that clinicians are ordering DecisionDx®-SCC for the intended high-risk cutaneous squamous cell carcinoma (SCC) patient population and that use of the test’s results can lead to risk-aligned changes in patient management strategies.

Aulos Bioscience today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for AU-007, a monoclonal antibody computationally designed by Biolojic Design.

Sagimet Biosciences announced today that it will present three abstracts at The Liver Meeting of the American Association for the Study of Liver Diseases (AASLD), taking place November 4-8, 2022, in Washington, DC.

Nuvo Pharmaceuticals Inc. today announced it expects to release its third quarter 2022 financial results before markets open on Monday, November 14, 2022.

Bausch Health Companies Inc. and its dermatology business, Ortho Dermatologics, recently announced the launch of the Podiatry Board Review Challenge, a new professional educational resource.

Sonnet BioTherapeutics Holdings, Inc. announced today a collaboration agreement with Janssen Biotech, Inc.

Mosaic ImmunoEngineering today announced that two research grants totaling $4.3 million from the National Cancer Institute (NCI) were awarded to the Company’s collaborating scientists and their respective academic institutions.

Håkan Björklund, the current Chairman of the Board of Swedish Orphan Biovitrum AB, has notified the Nomination Committee that he is not available for re-election at the Annual General Meeting 2023.

Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, November 1, 2022, at 8:30 a.m. Eastern Time to report its third quarter 2022 financial results and corporate activities.